FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309558909> ?p ?o ?g. }

• W4309558909 abstract "Multiple sclerosis (MS) is a T-cell-mediated chronic inflammatory disease of the central nervous system (CNS) that manifests in young adults as a predominant cause of severe neurological disability, which imposes a heavy economic and psychological burden on the patient's family.1 Currently, there are many shortcomings in the efficacy of drugs to control the progression of the disease. These unmet clinical needs stem from incompletely understood immune mechanisms of MS. Past research on autoreactive T cells in MS patients has been limited to blood and cerebrospinal fluid.2 Of note, the location and factors that determine the initiation and evolution of autoreactive T cells, and the impact of these factors on the progression of MS disease, are still poorly understood. Bone marrow harbours haematopoietic stem and progenitor cells (HSPCs) that give rise to all immune cell types.3 Recent evidence has demonstrated the skull and vertebral bone marrow as a key reservoir of myeloid cells and lymphocytes for the meninges and CNS parenchyma.4, 5 These findings are partially supported by a previous study showing skull bone marrow and the brain surface are connected by direct vascular channels that enable myeloid cell migration into brain.6 Emerging evidence indicates that infectious or inflammatory stimuli induces adaptation of bone marrow HSPCs, leading to an increase in the output of myeloid cells by activation of lineage-specific transcription factors.7 These observations suggest a potential link between the activation of bone marrow HSPCs and the co-operation between the innate and adaptive immunity, raising several interesting questions particularly including whether this occurs in patients with chronic inflammatory diseases and its impact on disease outcome.8 The aetiology of MS is focused on myelin-reactive T cells that infiltrate the CNS to cause demyelinating lesions.9 One recently study coupled single cell sequencing and flow cytometry analysis of bone marrow HSPCs and their downstream cellular lineages in MS patients.8 The authors found that bone marrow HSPCs were predominantly skewed towards myeloid lineage concomitant with an increase of transcription factors in myeloid lineage but not lymphoid lineage. This finding is unexpected because MS is thought to be a T-cell-mediated autoimmune CNS inflammatory disease and the alterations in bone marrow myeloid cells have not been comprehensively depicted. Notably, the augmented myelopoiesis in bone marrow of MS patients was accompanied by enhanced clonal expansion of T cells. These and other observations led the authors to conclude that bone marrow HSPCs can sense and adapt to systemic immune activation in MS patients, a process that drives CNS inflammation and autoimmunity. To determine the fate of HSPCs and their downstream cellular lineages, the authors mirrored these observations in experimental autoimmune encephalomyelitis, a mouse model of MS. Lineage tracing revealed that increased bone marrow myelopoiesis led to augmented output of monocytes and neutrophils that subsequently invaded the CNS. Of interest, they showed that myelin-reactive T cells migrated into the bone marrow compartment in a CXCL12-CXCR4 dependent manner. Subsequently, the myelin-reactive T cells highly expressed CCL5, which resulted in bone marrow myelopoiesis in a CCL5-CCR5 axis dependent manner (Figure 1). The aberrant bone marrow myelopoiesis was ablated in bone marrow chimeric mice reconstituted with CCR5−/- HSCs or wild type mice receiving a CCR5 inhibitor, suggesting a detrimental role of CCL5-CCR5 axis in myelopoiesis that drives CNS inflammation and demyelination.8 These findings extend the previous understanding of autoreactive T cells within lymph organs and CNS into bone marrow in MS, implicating bone marrow as a treatment target to reset and correct the aberrant immune response leading to CNS autoimmunity in MS. This notion is supported by results from clinical trials, in which autologous haematopoietic stem cell transplantation, i.e. bone marrow transplantation, can arrest neurological deterioration and prolong medication-free interval in patients with aggressive MS.10 Given that immune suppressant drugs to treat MS often have side effects of suppressing myelopoiesis, it seems plausible to speculate that the reduced myelopoiesis may actually contribute to the benefit of these medications. Future investigations are required to identify possible therapies targeting bone marrow to restore immune homeostasis, and thus to control CNS autoimmune neuroinflammation. This work was supported in part by National Science Foundation of China (82171284, 82200279), National Key Research and Development Project of China (2021ZD0202400), Science and Technology Development Fund of Tianjin Education Commission for higher Education grant (2021ZD035) and Tianjin Key Medical Discipline (Specialty) Construction Project. The authors declare no competing interests exist." @default.
• W4309558909 created "2022-11-28" @default.
• W4309558909 creator A5002160765 @default.
• W4309558909 creator A5081453356 @default.
• W4309558909 date "2022-11-01" @default.
• W4309558909 modified "2023-10-09" @default.
• W4309558909 title "Bone marrow brews central nervous system inflammation and autoimmunity" @default.
• W4309558909 cites W2042450855 @default.
• W4309558909 cites W2888160268 @default.
• W4309558909 cites W2952520385 @default.
• W4309558909 cites W2969144267 @default.
• W4309558909 cites W3094093529 @default.
• W4309558909 cites W3159288344 @default.
• W4309558909 cites W3164896384 @default.
• W4309558909 cites W3165520347 @default.
• W4309558909 cites W4282960093 @default.
• W4309558909 cites W4283165220 @default.
• W4309558909 doi "https://doi.org/10.1002/ctm2.1125" @default.
• W4309558909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36412512" @default.
• W4309558909 hasPublicationYear "2022" @default.
• W4309558909 type Work @default.
• W4309558909 citedByCount "0" @default.
• W4309558909 crossrefType "journal-article" @default.
• W4309558909 hasAuthorship W4309558909A5002160765 @default.
• W4309558909 hasAuthorship W4309558909A5081453356 @default.
• W4309558909 hasBestOaLocation W43095589093 @default.
• W4309558909 hasConcept C109159458 @default.
• W4309558909 hasConcept C193419808 @default.
• W4309558909 hasConcept C201750760 @default.
• W4309558909 hasConcept C203014093 @default.
• W4309558909 hasConcept C2776914184 @default.
• W4309558909 hasConcept C2779282312 @default.
• W4309558909 hasConcept C2780007613 @default.
• W4309558909 hasConcept C28328180 @default.
• W4309558909 hasConcept C71924100 @default.
• W4309558909 hasConcept C86803240 @default.
• W4309558909 hasConcept C8891405 @default.
• W4309558909 hasConcept C95444343 @default.
• W4309558909 hasConceptScore W4309558909C109159458 @default.
• W4309558909 hasConceptScore W4309558909C193419808 @default.
• W4309558909 hasConceptScore W4309558909C201750760 @default.
• W4309558909 hasConceptScore W4309558909C203014093 @default.
• W4309558909 hasConceptScore W4309558909C2776914184 @default.
• W4309558909 hasConceptScore W4309558909C2779282312 @default.
• W4309558909 hasConceptScore W4309558909C2780007613 @default.
• W4309558909 hasConceptScore W4309558909C28328180 @default.
• W4309558909 hasConceptScore W4309558909C71924100 @default.
• W4309558909 hasConceptScore W4309558909C86803240 @default.
• W4309558909 hasConceptScore W4309558909C8891405 @default.
• W4309558909 hasConceptScore W4309558909C95444343 @default.
• W4309558909 hasFunder F4320321001 @default.
• W4309558909 hasIssue "11" @default.
• W4309558909 hasLocation W43095589091 @default.
• W4309558909 hasLocation W43095589092 @default.
• W4309558909 hasLocation W43095589093 @default.
• W4309558909 hasLocation W43095589094 @default.
• W4309558909 hasOpenAccess W4309558909 @default.
• W4309558909 hasPrimaryLocation W43095589091 @default.
• W4309558909 hasRelatedWork W1977841877 @default.
• W4309558909 hasRelatedWork W1978598034 @default.
• W4309558909 hasRelatedWork W1982854051 @default.
• W4309558909 hasRelatedWork W2038751426 @default.
• W4309558909 hasRelatedWork W2253242983 @default.
• W4309558909 hasRelatedWork W2285393345 @default.
• W4309558909 hasRelatedWork W2588548568 @default.
• W4309558909 hasRelatedWork W2784395700 @default.
• W4309558909 hasRelatedWork W3049162505 @default.
• W4309558909 hasRelatedWork W4313381867 @default.
• W4309558909 hasVolume "12" @default.
• W4309558909 isParatext "false" @default.
• W4309558909 isRetracted "false" @default.
• W4309558909 workType "article" @default.